Exercise, Shockwave, PRP, or Corticosteroid? What the Evidence Says About Chronic Tendon Pain

Abstract

Chronic tendon pain rarely has one universal answer. Current research supports progressive loading as a foundation for many tendinopathies, while shockwave therapy, corticosteroid injections, platelet-rich plasma (PRP), and platelet-rich fibrin (PRF) may have different roles depending on the tendon, diagnosis, chronicity, and patient goals. This evidence map compares short-term symptom relief with longer-term function and explains why treatment selection should follow examination and diagnosis, not marketing.

A data center technician develops persistent outer-elbow pain after months of tool handling. A runner cannot shake Achilles pain. An engineer has shoulder pain with overhead lifting. All three may hear the same menu: exercise, shockwave, cortisone, or a platelet-based injection.

The problem is that “tendinopathy” is not one disease in one location. The Achilles tendon is not the rotator cuff, and lateral elbow tendinopathy is not patellar tendinopathy. Even within one tendon, calcification, partial tearing, load exposure, age, metabolic health, symptom duration, and prior rehabilitation can change the clinical picture.

Evidence-based care starts with two questions: what is the diagnosis, and what outcome matters most?

The Baseline: Progressive Loading and Multimodal Rehabilitation

Across many common tendinopathies, exercise remains the most dependable starting point. This means more than stretching or repeating movements. Modern tendon rehabilitation progresses load in a measured way so that the tendon and surrounding muscle can tolerate more work over time.

A large systematic review examining 110 studies and nearly 4,000 participants found that resistance-exercise dose matters. Programs using external resistance and adequate recovery tended to produce better outcomes than lower-intensity approaches using body weight alone (Pavlova et al., 2023). In patellar tendinopathy, a randomized trial found progressive tendon-loading exercise produced better 24-week clinical outcomes than eccentric exercise alone (Breda et al., 2021).

This is relevant for engineers, Amazon associates, data center technicians, and athletes because the goal isn’t simply less tenderness. It is restored capacity: gripping, lifting, walking, climbing, running, reaching, or working a full shift without repeated flare-ups.

Useful rehabilitation may include:

• Isometric, eccentric, concentric, and heavy slow resistance work.
• Gradual exposure to job- or sport-specific loads.
• Strengthening adjacent muscle groups and correcting major kinetic-chain deficits.
• Load management rather than complete rest.
• Tracking pain response, function, and next-day recovery.

The evidence does not show that one loading style is always superior. Achilles clinical guidance emphasizes individualized exercise and progressive loading, while systematic reviews demonstrate meaningful uncertainty when comparing different loading programs head-to-head (Chimenti et al., 2024).

Shockwave Therapy: Promising, but Tendon-Specific

Extracorporeal shockwave therapy (ESWT) delivers acoustic energy into targeted tissue. It is noninvasive and is commonly considered when symptoms persist despite appropriate rehabilitation.

However, “shockwave works for tendons” is too broad. For chronic lateral elbow tendinopathy, a 2024 meta-analysis of six randomized trials found corticosteroid injection produced better outcomes at one month, while ESWT performed better at three and six months for pain and grip-related measures (Zhang et al., 2024).

Shoulder findings are even more diagnosis-dependent. For noncalcific rotator cuff tendinopathy, a 2024 review found only a small short-term pain improvement over sham ESWT and no clear functional superiority. By contrast, evidence for calcific rotator cuff disease is more favorable, especially with higher-energy protocols, although certainty remains limited and ultrasound-guided needling may outperform ESWT for some outcomes (Kamonseki et al., 2024; Brindisino et al., 2024).

For Achilles tendinopathy, evidence is mixed and of lower certainty. That makes shockwave an adjunct to consider, not an automatic replacement for progressive loading.

Corticosteroid Injection: Fast Relief Can Be a Different Goal

Corticosteroid injections can reduce pain quickly in selected conditions. The critical question is whether short-term relief translates into durable tendon recovery.

Lateral elbow evidence illustrates the tradeoff. Systematic reviews have found substantial short-term pain relief, followed by poorer intermediate outcomes and uncertain or unfavorable longer-term results compared with conservative care (Coombes et al., 2010; Olaussen et al., 2013).

That does not mean every corticosteroid injection is inappropriate. A randomized trial in chronic midportion Achilles tendinopathy found ultrasound-guided corticosteroid injection combined with exercise improved outcomes compared with placebo injection plus exercise. The important detail is that the injection was part of a structured rehabilitation strategy, not a stand-alone promise of tendon repair.

Clinicians must also consider location, tissue integrity, dose, injection technique, recurrence risk, and the possibility that pain relief could encourage a patient to reload the tendon faster than its capacity has recovered.

PRP and PRF: Biology Is Plausible, Outcomes Are Uneven

PRP concentrates platelets from the patient’s blood and is intended to deliver signaling proteins involved in tissue repair. PRF uses a fibrin-rich platelet preparation with different processing and growth-factor release characteristics. These biologic concepts are appealing, but biologic plausibility does not equal proven clinical benefit.

The strongest caution comes from Achilles research. In a multicenter randomized trial involving 240 adults with chronic midportion Achilles tendinopathy, a single PRP injection did not improve six-month tendon function compared with a sham procedure (Kearney et al., 2021). Recent meta-analyses have reached similar conclusions for Achilles tendinopathy.

Results in other tendons are less uniform. Some reviews suggest PRP may provide more durable benefit than corticosteroids for selected rotator cuff disorders, while other tendon-specific analyses show little or no advantage over placebo. Differences in PRP concentration, leukocyte content, injection number, tendon diagnosis, comparator treatment, and rehabilitation make studies difficult to combine.

PRF should not simply be treated as interchangeable with PRP. A 2025 systematic review found important preparation and release differences between PRP and injectable PRF, but direct comparative clinical evidence remains limited across medicine and is especially immature for common chronic tendinopathies (Miron et al., 2025).

Evidence Map: What Each Option May Offer

Progressive loading

Best supported as a first-line foundation for many tendon problems. Benefits are usually measured in weeks to months and depend heavily on adherence, adequate resistance, recovery, and appropriate progression.

Shockwave

A noninvasive adjunct with tendon-specific evidence. It may be more useful in some chronic elbow or calcific shoulder presentations than in noncalcific shoulder or Achilles conditions.

Corticosteroid

Can provide meaningful short-term symptom relief in selected patients, but do not mistake short-term improvement for tendon restoration. Long-term value varies by diagnosis.

PRP or PRF

Potential biologic options are available when conservative care has failed, but results vary substantially by tendon and protocol. PRF has less direct tendon evidence than PRP.

Why Diagnosis Comes Before the Procedure

Persistent tendon pain can overlap with partial tears, bursitis, joint disease, nerve irritation, referred spinal pain, inflammatory disease, or metabolic factors. Imaging can help in selected cases, but tendon appearance alone does not determine symptoms or treatment.

In an integrated setting, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, holds Texas Advanced Practice Nursing License #1191402, Prescriptive Authority #59628, and NPI #1205907805. He bridges structural chiropractic care and mechanical rehabilitation with functional medicine diagnostics and, when clinically indicated, advanced injection, infusion, shockwave, laser, regenerative, and pain-management therapies under collaborative medical oversight.

Dr. Maria Guadalupe Cardenas, MD, is board-certified in Internal Medicine, has more than 40 years of experience, and holds Texas Medical License #J2933 and NPI #1164426748. As Medical Director, Clinical Director, and Collaborative Physician at Injury Medical Clinic PA in El Paso, she oversees complex metabolic comorbidities, advanced laboratory interpretation, medical risk stratification, and coordination across rehabilitation and procedural care.

That multidisciplinary structure supports three practical safeguards:

• Beneficence: choose care that improves function, not merely the most marketable procedure.
• Non-maleficence: begin with lower-risk, noninvasive strategies when appropriate and escalate thoughtfully.
• Autonomy: explain the evidence, uncertainties, alternatives, costs, and recovery demands so the patient remains the decision-maker.

The Practical Bottom Line

For many chronic tendon problems, progressive loading is the foundation. Shockwave may be a reasonable adjunct in selected diagnoses. Corticosteroids can sometimes provide faster symptom relief, but their long-term role is more limited in several tendinopathies. PRP may help selected patients, yet strong benefits are not consistent across tendons, and PRF evidence is still developing.

The most scientific question is not, “Which procedure is best?” It is, “Which diagnosis, which tendon, which patient, which outcome, and which time horizon are we treating?”

A coordinated MD/NP and chiropractic evaluation can help answer those questions before treatment begins. The goal is a plan that improves tendon capacity, preserves patient choice, minimizes avoidable risk, and supports a safe return to work, training, and daily life.

---

References

Barreto, E. S. R., Antunes Júnior, C. R., Silva, I. C., et al. (2025). Is platelet-rich plasma effective in treating Achilles tendinopathy? A meta-analysis of randomized clinical trials. Clinical Orthopaedics and Related Research, 483(5), 779–790.

Breda, S. J., Oei, E. H. G., Zwerver, J., et al. (2021). Effectiveness of progressive tendon-loading exercise therapy in patients with patellar tendinopathy: A randomised clinical trial. British Journal of Sports Medicine, 55(9), 501–509.

Brindisino, F., Marruganti, S., Lorusso, D., Cavaggion, C., & Ristori, D. (2024). The effectiveness of extracorporeal shock wave therapy for rotator cuff calcific tendinopathy: A systematic review with meta-analysis. Physiotherapy Research International, 29(3), e2106.

Chimenti, R. L., Neville, C., Houck, J., et al. (2024). Achilles pain, stiffness, and muscle power deficits: Midportion Achilles tendinopathy revision—2024. Journal of Orthopaedic & Sports Physical Therapy, 54(12), CPG1–CPG32.

Coombes, B. K., Bisset, L., & Vicenzino, B. (2010). Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: A systematic review of randomised controlled trials. The Lancet, 376, 1751–1767.

Farshidfar, N., Amiri, M. A., Estrin, N. E., et al. (2025). Platelet-rich plasma versus injectable platelet-rich fibrin: A systematic review across all fields of medicine. Periodontology 2000, 99(1), 185–215.

Johannsen, F., Olesen, J. L., Øhlenschläger, T. F., et al. (2022). Effect of ultrasonography-guided corticosteroid injection vs placebo added to exercise therapy for Achilles tendinopathy: A randomized clinical trial. JAMA Network Open, 5(7), e2219661.

Kamonseki, D. H., da Rocha, G. M., Ferreira, V. M. L. M., Ocarino, J. M., & Pogetti, L. S. (2024). Extracorporeal shockwave therapy for the treatment of noncalcific rotator cuff tendinopathy: A systematic review and meta-analysis. American Journal of Physical Medicine & Rehabilitation, 103(6), 471–479.

Kearney, R. S., Ji, C., Warwick, J., et al. (2021). Effect of platelet-rich plasma injection vs sham injection on tendon dysfunction in patients with chronic midportion Achilles tendinopathy: A randomized clinical trial. JAMA, 326(2), 137–144.

Olaussen, M., Holmedal, Ø., Lindbæk, M., Brage, S., & Solvang, H. (2013). Treating lateral epicondylitis with corticosteroid injections or non-electrotherapeutical physiotherapy: A systematic review. BMJ Open, 3, e003564.

Pavlova, A. V., Shim, J. S. C., Moss, R., et al. (2023). Effect of resistance exercise dose components for tendinopathy management: A systematic review with meta-analysis. British Journal of Sports Medicine, 57(20), 1327–1334.

Stania, M., Malá, J., & Chmielewska, D. (2023). The efficacy of extracorporeal shock wave therapy as a monotherapy for Achilles tendinopathy: A systematic review and meta-analysis. Journal of Chiropractic Medicine, 22(4), 294–301.

Yuwarungsikul, C., Phisalaphong, K., Thamrongskulsiri, N., et al. (2026). Platelet-rich plasma provides modest but durable functional benefit over corticosteroid for rotator cuff tendinopathy: A systematic review and meta-analysis of randomized controlled trials. Knee Surgery, Sports Traumatology, Arthroscopy, 34(8), 2937–2950.

Zhang, L., Zhang, X., Pang, L., Wang, Z., & Jiang, J. (2024). Extracorporeal shock wave therapy versus local corticosteroid injection for chronic lateral epicondylitis: A systematic review with meta-analysis of randomized controlled trials. Orthopaedic Surgery, 16(11), 2598–2607.